CARE Ratings Share Price Target 2027: Base and Bull Targets Built on FY26 Earnings
- October 9, 2026
- Posted by: Ankit Jaiswal
- Category: Market
CARE Ratings share price Rs 1,540.20 (9 October 2026). Base target Rs 1,844, bull Rs 2,209, downside risk Rs 1,229. PE 25.7. 52W range Rs 1,392.70 to Rs 1,838.00.
Quick Answer
The CARE Ratings share price target for 2027 is Rs 1,844, about 19.7% above the current price of Rs 1,540.20. The bull case is Rs 2,209, and the downside risk level, which is not a target, is Rs 1,229. The base case assumes earnings per share grow 20.0% a year, a cap applied because the FY24 to FY26 pace was 29.9%, with the stock holding its PE of 25.7. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a CARE Ratings target price for 2027 should start with where the stock sits today. At Rs 1,540.20 on 9 October 2026, it is 16.2% below its 52-week high of Rs 1,838.00 and 10.6% above its 52-week low of Rs 1,392.70. That range spans 32% from low to high, so the entry point matters as much as the CARE Ratings price forecast itself.
This article builds the CARE Ratings share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario shows its assumptions, so you can see exactly how the Rs 1,844 base case and the Rs 2,209 bull case were reached, along with a downside risk level of Rs 1,229.
Click Here – Get Free Investment Predictions
CARE Ratings Stock Analysis: Company Overview and Key Stats
CARE Ratings (NSE: CARERATING) has a market capitalisation of Rs 4,631 crore. In FY26 it reported revenue of Rs 527.89 crore and net profit of Rs 173.70 crore. The table collects the figures the CARE Ratings share price target is built on.
| Metric | Value |
|---|---|
| Company | CARE Ratings |
| NSE Ticker | CARERATING |
| CMP (9 October 2026) | Rs 1,540.20 |
| 52-Week High | Rs 1,838.00 |
| 52-Week Low | Rs 1,392.70 |
| Market Cap | Rs 4,631 crore |
| PE Ratio (TTM) | 25.70 |
| Industry PE | 33.32 |
| Price to Book | 4.97 |
| Return on Equity | 18.36% |
| Debt to Equity | 0.03 |
| EPS (TTM) | Rs 59.80 |
| Dividend Yield | 1.43% |
| 12-Month Base Target | Rs 1,844 |
| Bull Case | Rs 2,209 |
| Downside Risk Level (not a target) | Rs 1,229 |
Why Is CARE Ratings Share Price Target Set at Rs 1,844 for 2027?
The base-case CARE Ratings stock target of Rs 1,844 applies a PE multiple of 25.70 to a forward EPS estimate of Rs 71.76. That EPS assumes 20.0% yearly growth, the pace from FY24 to FY26, and puts the target 19.7% above the current price. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the CARE Ratings Target Price: Five Years of Results
CARE Ratings grew revenue from Rs 274.82 crore in FY22 to Rs 527.89 crore in FY26, a compound annual growth rate of 17.7%. Net profit grew faster, from Rs 76.83 crore to Rs 173.70 crore (22.6% a year), which shows margin gains did part of the work and not just higher sales.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY22 | 274.82 | 76.83 | 25.31 | 17.00 |
| FY23 | 316.93 | 85.46 | 28.17 | 25.00 |
| FY24 | 378.38 | 102.56 | 33.67 | 18.00 |
| FY25 | 453.07 | 140.00 | 45.69 | 18.00 |
| FY26 | 527.89 | 173.70 | 56.83 | 22.00 |
FY26 revenue growth was 16.5%, close to the four-year average of 17.7%, and net profit moved up 24.1%. EPS rose from Rs 33.67 in FY24 to Rs 56.83 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
CARE Ratings converted 32.9% of FY26 revenue into net profit, against 30.9% in FY25, within a five-year range of 27.0% to 32.9%. EBITDA margin was 47.8% in FY26 versus 45.5% in FY25.
In the June 2026 quarter, revenue was Rs 126.48 crore, up 17.5% from the same quarter a year earlier, while net profit of Rs 32.99 crore was up 24.5%. EBITDA came in at Rs 49.43 crore, up 19.3% year on year. The next quarterly result is the first test of whether the earnings assumption holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.03, and shareholders’ equity grew from Rs 652.81 crore in FY22 to Rs 943.13 crore in FY26. Operating cash flow in FY26 was Rs 147.57 crore against capital expenditure of Rs 8.30 crore, leaving free cash flow of Rs 139.27 crore, or 3.0% of the current market capitalisation. In FY25 free cash flow was Rs 108.21 crore.
Valuation Check for the CARE Ratings Stock Target: PE, Price to Book and ROE
At a PE of 25.70 against an industry PE of 33.32, CARE Ratings trades at a discount to its industry. Price to book is 4.97 on a book value of Rs 309.43 per share, and return on equity is 18.36%. A PE of 25.70 equals an earnings yield of 3.9%, and the FY26 dividend of Rs 22.00 per share gives a yield of 1.43%.
Shareholding Pattern and Institutional Holding
The latest filing shows no promoter holding in CARE Ratings, so ownership rests with institutions and public shareholders. Foreign institutional investors (FII) held 23.41% and domestic institutions (DII) held 31.58%, which puts total institutional holding at 54.99%. FII holding fell from 24.62% in June 2025 to 23.41% in June 2026. Public shareholders own the remaining 45.01%. A meaningful institutional holding adds a layer of research coverage and trading depth.
CARE Ratings Share Price Targets for the Short Term and 12 Months
Short Term CARE Ratings Stock Target Levels: Technical Setup
At Rs 1,540.20 on 9 October 2026, CARE Ratings trades below its 50-day simple moving average of Rs 1,671.21 and below its 200-day exponential moving average of Rs 1,632.18. The 14-day RSI reads 20.8, which is oversold territory, and the MACD line sits below its signal line. The nearest resistance level is Rs 1,632.18 (200-day exponential moving average) and the nearest support is Rs 1,392.70 (52-week low). A sustained move above Rs 1,632.18 would improve the short-term setup, while a close below Rs 1,392.70 would shift attention to the next support.
12 Month CARE Ratings Target Price for 2027
The 12-month target for CARE Ratings is Rs 1,844: forward EPS of Rs 71.76 at a PE of 25.70. That is 19.7% above Rs 1,540.20. It would also push the stock above its 52-week high of Rs 1,838.00.
How EPS Growth and PE Multiple Change the CARE Ratings Target Price
| EPS Growth | PE 20.56 | PE 25.70 | PE 29.55 |
|---|---|---|---|
| 0.0% (EPS Rs 59.80) | Rs 1,229 | Rs 1,537 | Rs 1,767 |
| 20.0% (EPS Rs 71.76) | Rs 1,475 | Rs 1,844 | Rs 2,121 |
| 25.0% (EPS Rs 74.75) | Rs 1,537 | Rs 1,921 | Rs 2,209 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the CARE Ratings price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for CARE Ratings Stock Target in 2027
Bull Case Rs 2,209
The bull case CARE Ratings price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 74.75, and a PE multiple that rises 15% to 29.55. That gives Rs 2,209, 43.4% above the current price and above the 52-week high of Rs 1,838.00, so the stock would have to set a fresh 52-week high.
Downside Risk Level Rs 1,229
The downside risk level is not a target. It assumes EPS stays flat at Rs 59.80 and the PE falls 20% to 20.56. That gives Rs 1,229, 20.2% below the current price and below the 52-week low of Rs 1,392.70.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 25.0% | 29.55 | Rs 2,209 | +43.4% |
| Base Case | 20.0% | 25.70 | Rs 1,844 | +19.7% |
| Downside Risk | 0.0% | 20.56 | Rs 1,229 | -20.2% |
Key Risks to the CARE Ratings Target Price for 2027
Growth Slowdown Risk for the CARE Ratings Price Target
Revenue in the June 2026 quarter was up 17.5% year on year, and FY26 revenue growth was 16.5%. If growth slows from here, the EPS estimate behind the CARE Ratings stock target will need revising.
Liquidity and Size Risk
CARE Ratings has a market capitalisation of Rs 4,631 crore. Institutional holding is 54.99%, and the latest filing shows no promoter holding. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.
Valuation and Margin Risk
Net margin was 32.9% in FY26, and a squeeze from higher costs or weaker pricing would hit earnings first. At a PE of 25.70 versus an industry PE of 33.32, a de-rating toward the downside-risk PE of 20.56 would cut the price even if earnings hold.
Market and Technical Risk
The stock trades 16.2% below its 52-week high, with an RSI of 20.8 and a MACD reading below its signal line. Broader market weakness can override company fundamentals in the short term.
How to Invest in CARE Ratings
Start with the live price and volume. Any CARE Ratings share price target is only as current as the data behind it, and the data here is as of 9 October 2026, so refresh the Rs 1,540.20 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check CARE Ratings’ PE, ROE, debt and shareholding in one place.
Check CARE Ratings fundamentals on the Univest Screener
Then compare the three CARE Ratings target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track CARE Ratings live price and get daily stock recommendations.
Conclusion
The CARE Ratings share price target for 2027 is Rs 1,844 in the base case, with Rs 2,209 as the bull case. The support for that view is arithmetic you can check: EPS grew 29.9% a year over FY24 to FY26, and the stock trades at a PE of 25.70. The risks are equally concrete, including a stock that sits 16.2% below its 52-week high and a downside scenario that cuts the price 20% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on CARE Ratings Share Price Target 2027
What is the CARE Ratings share price target for 2027?
Ans. The base-case CARE Ratings share price target for 2027 is Rs 1,844, with Rs 2,209 as the bull case. The downside risk level, which is not a target, is Rs 1,229. These are model estimates from reported earnings and the current PE, not guaranteed outcomes.
What is the CARE Ratings share price today?
Ans. As of 9 October 2026, 12:52 PM IST, CARE Ratings trades at Rs 1,540.20, down 0.14% on the day. The 52-week range is Rs 1,392.70 to Rs 1,838.00.
Is CARE Ratings a buy or sell at the current price?
Ans. The data is mixed rather than one-sided: EPS has grown 29.9% a year over FY24 to FY26, but the stock is 16.2% below its 52-week high. Whether CARE Ratings fits your portfolio depends on your time horizon and risk appetite, so consult a SEBI-registered advisor before investing. This article is not investment advice.
What are the bull case target and downside risk level for CARE Ratings shares?
Ans. The bull case target is Rs 2,209, which assumes 25.0% EPS growth and a PE of 29.55. The downside risk level is Rs 1,229, which assumes flat EPS and a PE of 20.56. It marks a risk, not a target.
What are the main risks to the CARE Ratings price target?
Ans. The main risks are slower revenue growth, a small market capitalisation of Rs 4,631 crore, a PE de-rating and short-term weakness in the broader market. Each is covered in the risk section above.
What is the PE ratio of CARE Ratings and how does it compare with the industry?
Ans. The PE ratio of CARE Ratings is 25.70 against an industry PE of 33.32. Price to book is 4.97 and return on equity is 18.36%. The base case in the CARE Ratings price target holds this PE constant.
Who owns CARE Ratings, and what is the promoter holding?
Ans. The latest filing shows no promoter holding in CARE Ratings. FII held 23.41%, DII held 31.58% and the public held 45.01%.
What were CARE Ratings’ latest quarterly results?
Ans. In the June 2026 quarter, CARE Ratings reported revenue of Rs 126.48 crore (up 17.5% year on year) and net profit of Rs 32.99 crore (up 24.5%).
